Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03111329
Other study ID # GRASS-1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 6, 2017
Est. completion date July 30, 2021

Study information

Verified date May 2024
Source Institute for the Care of Mother and Child, Prague, Czech Republic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study aims to compare routine assessment of gastric residuals versus no assessment of residuals in preterm neonates with respect to time taken for achieving full enteral feeding and the incidence of possible complications, such as feeding intolerance, necrotizing enterocolitis, sepsis etc.


Description:

In general, regular assessment of gastric residuals and itsĀ“ evaluation prior to every feeding is considered standard practice for preterm neonates in neonatal intensive care units. It is believed useful to confirm correct placement of the orogastric or nasogastric tube and thought of as necessary to aid the decision of enteral feeding advancement by informing about possible remains of contents from previous feeding. Furthermore, evaluation of gastric residuals is routinely performed in order to assess for feeding intolerance and used as a possible indicator of risk for development of necrotizing enterocolitis. However there is conflicting evidence to support the approach of routine gastric residuals assessment and it seems unclear whether it confers any clinical benefit. Withholding of enteral feeding or cessation of advancement in the amounts given due to misinterpretation of routine gastric aspirates may have a negative impact on the preterm neonate. This can potentially involve prolonged indwelling of venous catheters, higher risk of infection and growth restriction with potentially worse developmental outcome in particular for very low birth weight infants. This randomized controlled clinical study aims to compare a control group with regular assessment and evaluation of gastric residuals and an intervention group with no routine assessment of residuals prior to feeding advancement, for the time taken to reach full enteral feeding and for occurrence of any observed complications including necrotizing enterocolitis.


Recruitment information / eligibility

Status Completed
Enrollment 95
Est. completion date July 30, 2021
Est. primary completion date July 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 26 Weeks to 30 Weeks
Eligibility Inclusion Criteria: - Preterm neonate, born between 26+0 and 30+0 weeks of gestation - Birth weight below 1500g - Parental informed consent obtained Exclusion Criteria: - Intrauterine growth retardation (birth weight below 5th centile for given gestational age and gender) - Life-threatening events requiring full resuscitation at the delivery room (severe hypoxia, bleeding), and persistently raised lactate value of more than 5 mmol/l - Circulatory instability requiring treatment with inotropes - Highly suspected early onset sepsis with alteration of general clinical state, in particular with worsened peripheral perfusion and circulatory decompensation prior to study begin (during the first 6 hours after admission to NICU) - Known malformations of gastrointestinal tract, known diagnosis of congenital diaphragmatic hernia, any other life-limiting serious congenital malformations

Study Design


Intervention

Other:
No aspiration of gastric residuals
No assessment of gastric residuals will be performed prior to administering 3-hourly feeds with increasing amounts of the feeds given as per a predefined plan

Locations

Country Name City State
Czechia Institute for the Care of Mother and Child Prague
Ireland Coombe Women and Infants University Hospital Dublin

Sponsors (2)

Lead Sponsor Collaborator
Institute for the Care of Mother and Child, Prague, Czech Republic Coombe Women and Infants University Hospital

Countries where clinical trial is conducted

Czechia,  Ireland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of days taken to achieve full enteral feeding (i.e. dose of 100ml/kg/day) Time taken (in hours) to reach full enteral feeding, defined as overall dose of 100ml of feeds/kg of birth weight/ day 5 days after delivery for yes or no answer to whether full enteral feeding has been achieved, thereafter daily for the first three weeks until full enteral feeding has been reached
Secondary Withholding of enteral feeding The need to withhold enteral feeds due to clinical situation as per clinical judgement of the clinician in charge Through first (on average) two to three weeks of the study until full enteral feeding is achieved.
Secondary Total duration of parenteral infusion The length of time (in hours) that parenteral infusion is needed Through first (on average) two to three weeks of the study until full enteral feeding is achieved.
Secondary Total duration of indwelling central venous catheter The length of time (in hours) that an indwelling central venous catheter is needed Through first (on average) two to three weeks of the study until full enteral feeding is achieved.
Secondary Hypoglycaemia Any episodes of hypoglycaemia (value less than 2,5 mmol/l) after attainment of full enteral feeding Through first (on average) two to three weeks of the study until full enteral feeding is achieved.
Secondary Late onset sepsis The incidence of late onset sepsis Duration of hospitalization, an average of 8-15 weeks
Secondary Necrotizing enterocolitis The incidence of necrotizing enterocolitis Duration of hospitalization, an average of 8-15 weeks
Secondary Spontaneous intestinal perforation The incidence of spontaneous intestinal perforation Duration of hospitalization, an average of 8-15 weeks
Secondary Bronchopulmonary dysplasia Incidence of bronchopulmonary dysplasia At timepoint of reached 36 gestational weeks of the neonate
Secondary Intraventricular and periventricular haemorrhage The incidence of intraventricular and periventricular haemorrhage (stage I-IV) Duration of hospitalization, an average of 8-15 weeks
Secondary Retinopathy of prematurity Incidence of retinopathy of prematurity (stage I-V) Duration of hospitalization, an average of 8-15 weeks
Secondary Neurodevelopment Assessment of neurodevelopmental outcome Follow up at 24 months of corrected age of the child
See also
  Status Clinical Trial Phase
Recruiting NCT03670732 - CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure N/A
Completed NCT05322161 - Yoga in the NICU for Parents Study N/A
Recruiting NCT04542096 - Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
Recruiting NCT04911452 - Creating a Calmer NICU: Optimizing Growth and Brain Development in Preterm Infants N/A
Recruiting NCT02901652 - NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome N/A
Completed NCT02148965 - Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial N/A
Terminated NCT02032511 - Comparison of RAM Cannula Nasal Continuous Positive Airway Pressure Versus Infant Flow Nasal Continuous Positive Airway Pressure (NCPAP) N/A
Completed NCT02273843 - A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset Sepsis Phase 1
Completed NCT01721629 - Weaning of Nasal Continuous Positive Airway Pressure (CPAP) in Premature Infants N/A
Terminated NCT01819532 - Milking the Umbilical Cord Versus Immediate Clamping in Pre-term Infants < 33 Weeks N/A
Completed NCT01523769 - Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants N/A
Completed NCT01478711 - Comprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants N/A
Completed NCT00951860 - Assessment of Autonomic Maturation in Neonatal Period and Early Neural Development From a Longitudinal Prospective Cohort N/A
Completed NCT00787124 - Transfusions and Nitric Oxide Level in Preterm Infants
Completed NCT00749008 - Study of Generalized Movements for Early Prediction of Cerebral Palsy N/A
Terminated NCT00486395 - Will CPAP Reduce Length Of Respiratory Support In Premature Infants? Phase 3
Terminated NCT01208493 - Dietary Protein in the Very-low-birth-weight Infant N/A
Completed NCT00527956 - Facilitation and Barriers to Breastfeeding in the NICU N/A
Completed NCT03372590 - NEO Rehab for Infants at Risk of Cerebral Palsy N/A
Completed NCT00033917 - Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial Phase 3